Cargando…

Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery

The most common endocrine disease in obesity is hypothyroidism and secondary endocrine alterations, including abnormal thyroid function, are frequent in obesity. It is unclear whether impaired thyroid function is the cause or the consequence of increased adiposity; furthermore, there are no clear da...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordido, María, Juiz-Valiña, Paula, Urones, Paula, Sangiao-Alvarellos, Susana, Cordido, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911439/
https://www.ncbi.nlm.nih.gov/pubmed/35268429
http://dx.doi.org/10.3390/jcm11051340
_version_ 1784666806109077504
author Cordido, María
Juiz-Valiña, Paula
Urones, Paula
Sangiao-Alvarellos, Susana
Cordido, Fernando
author_facet Cordido, María
Juiz-Valiña, Paula
Urones, Paula
Sangiao-Alvarellos, Susana
Cordido, Fernando
author_sort Cordido, María
collection PubMed
description The most common endocrine disease in obesity is hypothyroidism and secondary endocrine alterations, including abnormal thyroid function, are frequent in obesity. It is unclear whether impaired thyroid function is the cause or the consequence of increased adiposity; furthermore, there are no clear data regarding the best way to dose levothyroxine for patients with both hypothyroidism and obesity, and the effect of bariatric surgery (BS). The aim of the present article is to review some controversial aspects of the relation between obesity and the thyroid: (1) Thyroid function in obesity and the effect of BS (2) Thyroid hormone treatment (THT) in obese patients with hypothyroidism and the effect of BS. In summary: In morbidly obese patients, TSH is moderately increased. Morbid obesity has a mild central resistance to the thyroid hormone, reversible with weight loss. In morbidly obese hypothyroid patients, following weight loss, the levothyroxine dose/kg of ideal weight did not change, albeit there was an increment in the levothyroxine dose/kg of actual weight. From a clinical practice perspective, in morbid obesity, diagnosing mild hypothyroidism is difficult, BS improves the altered thyroid function and THT can be adapted better if it is based on ideal weight.
format Online
Article
Text
id pubmed-8911439
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89114392022-03-11 Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery Cordido, María Juiz-Valiña, Paula Urones, Paula Sangiao-Alvarellos, Susana Cordido, Fernando J Clin Med Review The most common endocrine disease in obesity is hypothyroidism and secondary endocrine alterations, including abnormal thyroid function, are frequent in obesity. It is unclear whether impaired thyroid function is the cause or the consequence of increased adiposity; furthermore, there are no clear data regarding the best way to dose levothyroxine for patients with both hypothyroidism and obesity, and the effect of bariatric surgery (BS). The aim of the present article is to review some controversial aspects of the relation between obesity and the thyroid: (1) Thyroid function in obesity and the effect of BS (2) Thyroid hormone treatment (THT) in obese patients with hypothyroidism and the effect of BS. In summary: In morbidly obese patients, TSH is moderately increased. Morbid obesity has a mild central resistance to the thyroid hormone, reversible with weight loss. In morbidly obese hypothyroid patients, following weight loss, the levothyroxine dose/kg of ideal weight did not change, albeit there was an increment in the levothyroxine dose/kg of actual weight. From a clinical practice perspective, in morbid obesity, diagnosing mild hypothyroidism is difficult, BS improves the altered thyroid function and THT can be adapted better if it is based on ideal weight. MDPI 2022-02-28 /pmc/articles/PMC8911439/ /pubmed/35268429 http://dx.doi.org/10.3390/jcm11051340 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Cordido, María
Juiz-Valiña, Paula
Urones, Paula
Sangiao-Alvarellos, Susana
Cordido, Fernando
Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery
title Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery
title_full Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery
title_fullStr Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery
title_full_unstemmed Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery
title_short Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery
title_sort thyroid function alteration in obesity and the effect of bariatric surgery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911439/
https://www.ncbi.nlm.nih.gov/pubmed/35268429
http://dx.doi.org/10.3390/jcm11051340
work_keys_str_mv AT cordidomaria thyroidfunctionalterationinobesityandtheeffectofbariatricsurgery
AT juizvalinapaula thyroidfunctionalterationinobesityandtheeffectofbariatricsurgery
AT uronespaula thyroidfunctionalterationinobesityandtheeffectofbariatricsurgery
AT sangiaoalvarellossusana thyroidfunctionalterationinobesityandtheeffectofbariatricsurgery
AT cordidofernando thyroidfunctionalterationinobesityandtheeffectofbariatricsurgery